Emre Arslan

513 total citations
7 papers, 265 citations indexed

About

Emre Arslan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Emre Arslan has authored 7 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Emre Arslan's work include Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (2 papers) and Lung Cancer Research Studies (2 papers). Emre Arslan is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (2 papers) and Lung Cancer Research Studies (2 papers). Emre Arslan collaborates with scholars based in United States, India and Germany. Emre Arslan's co-authors include Kunal Rai, Katarzyna Tomczak, Herbert Levine, Rama Soundararajan, Abhijeet Deshmukh, Petra den Hollander, Mohit Kumar Jolly, Suhas Vasaikar, Shubham Tripathi and Priyanka Chakraborty and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Clinical Cancer Research.

In The Last Decade

Emre Arslan

6 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emre Arslan United States 4 148 106 93 45 25 7 265
Norihiro Nakada Japan 12 272 1.8× 130 1.2× 68 0.7× 38 0.8× 12 0.5× 20 407
Rocío López‐Vacas Spain 10 159 1.1× 78 0.7× 96 1.0× 67 1.5× 10 0.4× 23 316
Cheng Du China 12 235 1.6× 96 0.9× 83 0.9× 55 1.2× 27 1.1× 21 370
Zsuzsanna Mihály Hungary 8 194 1.3× 84 0.8× 98 1.1× 107 2.4× 19 0.8× 28 358
Zhiwei Zhao China 13 244 1.6× 65 0.6× 178 1.9× 34 0.8× 11 0.4× 29 358
Nüket Eliyatkın Türkiye 6 104 0.7× 102 1.0× 94 1.0× 32 0.7× 7 0.3× 26 268
Francesca Chemi United Kingdom 8 118 0.8× 140 1.3× 110 1.2× 35 0.8× 15 0.6× 14 291
Cathrine Holland United Kingdom 12 279 1.9× 134 1.3× 127 1.4× 35 0.8× 35 1.4× 25 501
Tsunehisa Nomura Japan 9 121 0.8× 137 1.3× 80 0.9× 37 0.8× 9 0.4× 33 292
Yanfei Shao China 11 185 1.3× 74 0.7× 123 1.3× 121 2.7× 9 0.4× 29 311

Countries citing papers authored by Emre Arslan

Since Specialization
Citations

This map shows the geographic impact of Emre Arslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emre Arslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emre Arslan more than expected).

Fields of papers citing papers by Emre Arslan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emre Arslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emre Arslan. The network helps show where Emre Arslan may publish in the future.

Co-authorship network of co-authors of Emre Arslan

This figure shows the co-authorship network connecting the top 25 collaborators of Emre Arslan. A scholar is included among the top collaborators of Emre Arslan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emre Arslan. Emre Arslan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Arslan, Emre, et al.. (2024). Diabetes Risk Prediction With Different Machine Learning Algorithms. Istanbul Technical University Academic Open Archive (Istanbul Technical University). 403–407. 1 indexed citations
2.
Truong, Danh D., Emre Arslan, Veena Kochat, et al.. (2024). Abstract 130: Multi-omic analysis of desmoplastic small sound cell tumors reveal distinct epithelial and neuroendocrine lineages. Cancer Research. 84(6_Supplement). 130–130.
3.
Osman, Abdullah A., Emre Arslan, Chieko Michikawa, et al.. (2023). Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 29(7). 1344–1359. 32 indexed citations
4.
Truong, Danh D., Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, et al.. (2023). Abstract 1196: The epigenetic impact and therapeutic opportunity of AR-directed therapy for DSRCT. Cancer Research. 83(7_Supplement). 1196–1196. 1 indexed citations
5.
Deshmukh, Abhijeet, Suhas Vasaikar, Katarzyna Tomczak, et al.. (2021). Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing. Proceedings of the National Academy of Sciences. 118(19). 168 indexed citations
6.
Arslan, Emre, Jonathan E. Schulz, & Kunal Rai. (2021). Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(2). 188588–188588. 26 indexed citations
7.
Terranova, Christopher, Kristina M. Stemler, Sabrina L. Jeter-Jones, et al.. (2021). Reprogramming of H3K9bhb at regulatory elements is a key feature of fasting in the small intestine. Cell Reports. 37(8). 110044–110044. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026